News
Psilocybin news and legal updates
The latest laws taking effect, bills moving through state legislatures, the research we cite, and every change to the directory.
Live feed
New laws, bills and providers our daily search finds, posted automatically each morning. Each find is labeled once PsiloAtlas has checked its source, always read the linked source before acting on one.
- Resource · US · Found November 7, 2026 · Reviewed, source checkedKetamine-provider directory for regional discoveryThe professional association provides provider-discovery resources useful for Northeast and Midwest coverage, although association inclusion is not license verification or evidence of a recent opening.Source: American Society of Ketamine Physicians, Psychotherapists & Practitioners ↗
- Resource · US · Found November 7, 2026 · Reviewed, source checkedNortheast and Midwest clinic discovery: SPRAVATO treatment-center locatorThe manufacturer's treatment-center locator supports finding esketamine providers by location, including Northeast and Midwest markets, but does not establish when a clinic opened or independently confirm its professional licenses.Source: SPRAVATO / Johnson & Johnson ↗
- Provider · NY · Found November 7, 2026 · Reviewed, source checkedNew York ketamine provider to review: NushamaIts official website describes a New York City ketamine-treatment practice and identifies its clinical team and location; licensing and any recent opening or expansion remain unconfirmed.Source: Nushama ↗
- Provider · US · Found November 4, 2026 · Reviewed, source checkedFluence: psychedelic integration training and professional educationIts official website documents psychedelic integration education for clinicians rather than a licensed treatment service; a recent program change as of November 2026 has not been verified.Source: Fluence ↗
- Provider · Mexico · Found November 2, 2026 · Reviewed, source checkedAmbio Life Sciences: ibogaine treatment provider in MexicoThe provider’s official website identifies its Mexico-based ibogaine services and team, supporting a directory lead, but its license and any recent operational changes are unconfirmed.Source: Ambio Life Sciences ↗
- Provider · Mexico · Found November 2, 2026 · Reviewed, source checkedBeond: ibogaine treatment provider in MexicoThe provider’s official website describes its Mexico-based ibogaine program and clinical team, supporting a directory lead, but its license and any recent operational changes are unconfirmed.Source: Beond ↗
- Legal · CO · Found October 31, 2026 · Reviewed, source checkedColorado’s 2024 amendments to regulated natural-medicine lawThe official SB24-198 record documents amendments to Colorado’s regulated natural-medicine framework relevant to licensing and service operations.Source: Colorado General Assembly ↗
- Resource · OR · Found October 30, 2026 · Reviewed, source checkedOregon Psilocybin Services licensing and regulatory resourcesThe official program portal provides access to licensing, licensee-directory, and regulatory information for checking service centers and facilitators, rather than establishing any particular newly issued license.Source: Oregon Health Authority ↗
- Bill · Vermont · Found October 28, 2026 · Reviewed, source checkedVermont S.114: An act relating to establishing the Psychedelic Therapy Advisory Working GroupEstablished an advisory working group to examine psychedelic therapy and make recommendations concerning its potential regulation.Source: State legislature ↗
- Legal · US · Found October 1, 2026 · Reviewed, source checkedCongressional psychedelics caucus publishes report on federal and state cooperation for therapeutic accessThe bipartisan PATH Caucus summarized expert input on integrating psilocybin, ibogaine and DMT therapy into US healthcare.Source: Marijuana Moment ↗
- Legal · UT · Found October 5, 2026 · Reviewed, source checked10th Circuit lets Utah continue prosecuting Singularism founder over religious psilocybin useThe Oct. 5, 2026 ruling overturned a lower-court order that had blocked the state case against Bridger Jensen.Source: Courthouse News Service ↗
- Legal · OR · Found October 9, 2026 · Reviewed, source checkedRedmond, Oregon voters to decide in November whether to end the city's ban on psilocybin service centersA "yes" vote extends the moratorium two more years; a "no" vote would allow licensed centers in the city.Source: Redmond Spokesman ↗
- Provider · OR · Found October 12, 2026 · Reviewed, source checkedStudy: Oregon's licensed psilocybin centers follow safety screening rules; sessions average about $1,900Researchers posing as clients found every center screened for psychiatric history and medications; none took insurance.Source: WashU Medicine ↗
- Legal · NM · Found October 6, 2026 · Reviewed, source checkedNew Mexico holds hearing on draft psilocybin therapy rules ahead of December launchThe state Department of Health presented draft rules on Oct. 2, 2026 and is targeting a December 2026 launch for its medical psilocybin program.Source: Santa Fe Reporter ↗
Latest legal updates
Laws and programs by the date they took effect, newest first.
- Aug 1, 2026LouisianaState psychedelic-assisted therapy initiative
- Jul 1, 2026GeorgiaClinic licensing framework enacted for FDA-approved drugs
- Jul 1, 2026MississippiState-backed ibogaine clinical trials
- May 22, 2026TennesseeState ibogaine clinical trial program
- Apr 14, 2026KentuckyState ibogaine research fund; no legal access
- Jan 20, 2026New JerseyHospital psilocybin pilot program
- Jan 1, 2026Czech RepublicMedical psilocybin framework effective in 2026
- Sep 26, 2025ArizonaFDA-approved psilocybin could be prescribed once rescheduled
- Jun 20, 2025New MexicoMedical program forming
- Jun 11, 2025TexasState-funded ibogaine trials; no legal access
- Sep 20, 2024AlaskaNo legal access; state psychedelic medicine task force
- Jul 1, 2024MarylandNo legal psilocybin access
State bills
Psychedelic bills we track, each linked to its official legislature page.
- Michigan · 2026 · introducedHB 6020: Participation in ibogaine clinical trialsOfficial bill
- Louisiana · 2026 · enactedSB 43: Provides relative to psychedelic-assisted therapyOfficial bill
- Pennsylvania · 2026 · introducedSB1149: Pharmaceutical synthetic psilocybin scheduling proposalOfficial bill
- Pennsylvania · 2025 · introducedHB1439: FDA-linked psilocybin access proposalOfficial bill
- New Mexico · 2025 · enactedSB 219: Medical Psilocybin ActOfficial bill
- New York · 2025 · introducedA2142A / S5303A: Allows growth, cultivation and adult use of psilocybin for certain health conditionsOfficial bill
- New York · 2025 · introducedA628: Natural hallucinogen adult-use proposalOfficial bill
- Arizona · 2025 · introducedHB 2871: Appropriation; ibogaine; clinical research studyOfficial bill
- Illinois · 2025 · introducedHB 1143: Compassionate Use and Research of Entheogens ActOfficial bill
- Illinois · 2025 · introducedSB 2184: Compassionate Use and Research of Entheogens ActOfficial bill
- New Jersey · 2025 · enactedS 2283: Pilot program for psilocybin research; makes an appropriationOfficial bill
- Washington · 2025 · introducedHB 1433: Concerning access to psychedelic substancesOfficial bill
- Washington · 2025 · introducedSB 5201: Concerning access to psychedelic substancesOfficial bill
- Maine · 2025 · failedLD 1034: An Act to Decriminalize Personal Possession of Therapeutic Amounts of Psilocybin for AdultsOfficial bill
- California · 2025 · enactedAB 1103: Controlled substances: researchOfficial bill
- Michigan · 2025 · introducedHB 4686: Allow psilocybin or psilocin under certain circumstancesOfficial bill
- Texas · 2025 · enactedSB 2308: Establishment of a consortium to conduct a clinical trial of ibogaine treatmentOfficial bill
- Utah · 2024 · enactedHB 167: Mental illness psychotherapy drug pilotOfficial bill
- Vermont · 2024 · enactedS.114: An act relating to the establishment of the Psychedelic Therapy Advisory Working GroupOfficial bill
- Maryland · 2024 · enactedSB 1009 / HB 548: Task Force on Responsible Use of Natural Psychedelic SubstancesOfficial bill
- Massachusetts · 2024 · failedQuestion 4: Natural psychedelic substances ballot measureOfficial bill
- California · 2023 · vetoedSB 58: Decriminalize certain natural psychedelicsOfficial bill
- Minnesota · 2023 · enactedHF 100: Psychedelic Medicine Task ForceOfficial bill
- Colorado · 2023 · enactedProposition 122 / SB23-290: Natural Medicine Health Act and implementing lawOfficial bill
- Washington · 2023 · enactedSB 5263: Psilocybin task force and pilotOfficial bill
- Texas · 2021 · enactedHB 1802: Psilocybin treatment research study for veteransOfficial bill
- Oregon · 2020 · enactedMeasure 109: Oregon Psilocybin Services ActOfficial bill
Research
Peer-reviewed studies cited on PsiloAtlas.
- Bogenschutz et al. (2022) Psilocybin-assisted psychotherapy vs placebo for alcohol use disorderJAMA Psychiatry
- Carhart-Harris et al. (2021) Trial of psilocybin versus escitalopram for depressionNew England Journal of Medicine
- Davis et al. (2018) The epidemiology of 5-MeO-DMT use: benefits, consequences, patterns of useJournal of Psychopharmacology
- Davis et al. (2021) Effects of psilocybin-assisted therapy on major depressive disorderJAMA Psychiatry
- Feifel et al. (2026) Phase 2b randomized trial of intranasal mebufotenin (BPL-003) in treatment-resistant depressionJAMA
- Goodwin et al. (2022) Single-dose psilocybin for a treatment-resistant episode of major depressionNew England Journal of Medicine
- Griffiths et al. (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancerJournal of Psychopharmacology
- Human hallucinogen research: guidelines for safety (Johnson, Richards & Griffiths, 2008)Journal of Psychopharmacology
- Johnson et al. (2014) Pilot study of psilocybin in the treatment of tobacco addictionJournal of Psychopharmacology
- Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Cherian et al., 2024)Nature Medicine
- Mitchell et al. (2021) MDMA-assisted therapy for severe PTSDNature Medicine
- Mitchell et al. (2023) MDMA-assisted therapy for moderate to severe PTSD: a phase 3 trialNature Medicine
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Carhart-Harris et al., 2012)PNAS
- Ot'alora G et al. (2018) MDMA-assisted psychotherapy for chronic PTSD: a randomized phase 2 trialJournal of Psychopharmacology
- Psychedelic harm reduction and integration: a transtheoretical model for clinical practice (Gorman et al., 2021)Frontiers in Psychology
- Raison et al. (2023) Single-dose psilocybin treatment for major depressive disorderJAMA
- Reckweg et al. (2023) Phase 1/2 trial of vaporized 5-MeO-DMT (GH001) in treatment-resistant depressionFrontiers in Psychiatry
- Ross et al. (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancerJournal of Psychopharmacology
Directory changes
- Provider · November 14, 2026Transcendental JonesBend, Oregon psilocybin facilitation practice led by licensed facilitator Tracy Jones, offering preparation, administration-session support and integration, with private journeys and retreats.
- Provider · November 12, 2026Trinity College Dublin & Tallaght University Hospital, Psychedelic Research GroupAcademic psychedelic research collaboration in Dublin studying psilocybin and related therapies. Research information only, not an open-access treatment or retreat service.
- Provider · November 12, 2026Rythmia Life Advancement CenterAyahuasca retreat program in Guanacaste, Costa Rica, advertising medical supervision and complementary wellness activities.
- Provider · November 12, 2026Douglas Institute, Ketamine Treatment TeamHospital ketamine treatment in Montreal for severe, treatment-resistant depressive disorders, provided by psychiatrists and nurses.
- Provider · November 12, 2026Qi Integrated HealthVancouver PsyQi program offering ketamine-assisted therapy with preparation, guided therapeutic sessions and integration support.
- Provider · November 12, 2026Empower Health Wellness CentreIndividual and small-group ketamine-assisted therapy in Vancouver, with medical and therapeutic assessments and integration sessions.
- Provider · November 12, 2026The Emerge ClinicMedically supervised ketamine-assisted psychotherapy in Gorleston-on-Sea, Norfolk, with preparation, integration and psychological support.
- Provider · November 12, 2026Mirabilis HealthMedically supervised ketamine-assisted psychotherapy in Newtownabbey, Northern Ireland, combining preparation, intramuscular treatment and integration.
- Provider · November 12, 2026Eulas Clinics, HamiltonConsultant-led ketamine-assisted psychotherapy in Hamilton, Scotland, with assessment and psychotherapeutic support.
- Provider · November 12, 2026Austin Ketamine CareAustin Ketamine Care advertises ketamine-assisted psychotherapy in Austin, TX. Services are provider-reported; professional licensing is unconfirmed. Provider-specific legal permissions have not been verified.
- Provider · November 12, 2026CanaryCareCanaryCare advertises Spravato (esketamine) treatment in Harrisville, WV. Services are provider-reported; professional licensing is unconfirmed. Provider-specific legal permissions have not been verified.
- Provider · November 12, 2026Lumin HealthLumin Health advertises Spravato (esketamine) treatment in Brookline, MA. Services are provider-reported; professional licensing is unconfirmed. Provider-specific legal permissions have not been verified.
- Provider · November 12, 2026Texas Ketamine & Wellness CenterTexas Ketamine & Wellness Center advertises ketamine therapy in Houston, TX. Services are provider-reported; professional licensing is unconfirmed. Provider-specific legal permissions have not been verified.
- Provider · November 12, 2026Heading HealthHeading Health advertises ketamine therapy and Spravato (esketamine) in San Antonio, TX. Services are provider-reported; professional licensing is unconfirmed. Provider-specific legal permissions have not been verified.
- Provider · November 12, 2026Avesta Ketamine & WellnessAvesta Ketamine & Wellness advertises IV ketamine, Spravato (esketamine) and ketamine-assisted psychotherapy in Norfolk, VA. Services are provider-reported; professional licensing is unconfirmed. Provider-specific legal permissions have not been verified.
- Legal · November 2, 2026Ketamine (nationwide): Legal by prescription
- Legal · November 2, 2026Netherlands: Truffles legal and sold openly
- Legal · November 2, 2026Mexico: Illegal; indigenous carve-out
- Legal · November 2, 2026Ecuador: No legal access; possession limits do not cover psilocybin
- Legal · November 2, 2026Maryland: No legal psilocybin access
- Legal · November 2, 2026Switzerland: Exceptional medical licenses
- Legal · November 2, 2026Federal (United States): Schedule I
- Legal · November 2, 2026Georgia: Clinic licensing framework enacted for FDA-approved drugs
- Legal · November 2, 2026Costa Rica: Controlled; personal use not penalized
- Guide · November 2, 2026Set, setting, and safety basicsThe foundations of harm reduction: mindset, environment, screening, and who should not participate.
- Guide · November 2, 2026Is this right for me? A screening primerThe health history, medications, and life circumstances that make psychedelic sessions unsafe or ill-timed.
- Guide · November 2, 2026Psilocybin and the default mode networkWhat brain-imaging studies suggest about psilocybin and the default mode network, and why the mechanism remains unsettled.
- Guide · November 2, 2026How to choose a facilitatorCredentials to verify, questions to ask, and the red flags that should end a consultation.
- Guide · November 2, 2026Psychedelics 101: the honest starting pointWhat these substances are, what they actually do, and the vocabulary you'll see everywhere else on this site.
- Resource · November 2, 2026ClinicalTrials.govSearch active psilocybin, MDMA, and ketamine trials by condition and location, the only lawful access in most states.
Want the full review log? See directory updates.